The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

Dear Dr. Roach: I am a breast cancer survivor whose cancer was 100% estrogen-responsive. I have completed five years of the ...

The MVA-BN vaccine showed an overall effectiveness of 57.8% (95% CI, 11.8-83.0) in reducing mpox cases at 14 days or longer after the first dose; however, the effectiveness was lower in people ...

Exploring the history of lifesaving infectious disease immunizations and how the Vaccines for Children Program has saved millions of lives.

Approved by the FDA in 2019, JYNNEOS was the first smallpox vaccine successfully developed under Project BioShield, a program created by the U.S. Congress in 2004 to accelerate the research ...

Smallpox vaccines work very quickly to protect people ... estrogen levels may be temporarily but significantly higher when first using these products. This is due to the thin lining of the ...

Smallpox vaccines work very quickly to protect people ... estrogen levels may be temporarily but significantly higher when first using these products. This is due to the thin lining of the ...